Fierce Healthcare August 23, 2019
FDA official Amy Abernethy, M.D. said the agency is encouraging interoperability and wants to speed the development of new therapies and medical technologies.
The Food and Drug Administration is in discussions with multiple stakeholders to create a universal unique medical device identifier to be stored in electronic health records and linked to patient outcomes to improve medical device surveillance, said FDA principal deputy commissioner Amy Abernethy, M.D.
Speaking at the Office of the National Coordinator for Health IT’s 3rd Interoperability Forum in Washington, D.C., Abernethy, who also serves as the FDA’s acting CIO, said the agency wants to advance interoperability and speed the development of new therapies and medical technologies.
The FDA also is looking to provide regulatory relief to...